These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Clinical risk factors for early complications after high-dose-rate endobronchial brachytherapy in the palliative treatment of lung cancer. Zaric B; Perin B; Jovelic A; Lalic N; Secen N; Kopitovic I; Antonic M Clin Lung Cancer; 2010 May; 11(3):182-6. PubMed ID: 20439194 [TBL] [Abstract][Full Text] [Related]
44. Palliation of dysphagia in advanced, metastatic or recurrent carcinoma oesophagus with high dose rate intraluminal brachytherapy--an eastern Indian experience of 35 cases. Ghosh S; Sau S; Mitra S; Manna A; Ghosh K J Indian Med Assoc; 2012 Jul; 110(7):449-52. PubMed ID: 23520668 [TBL] [Abstract][Full Text] [Related]
45. Phase III randomized trial comparing LDR and HDR brachytherapy in treatment of cervical carcinoma. Lertsanguansinchai P; Lertbutsayanukul C; Shotelersuk K; Khorprasert C; Rojpornpradit P; Chottetanaprasith T; Srisuthep A; Suriyapee S; Jumpangern C; Tresukosol D; Charoonsantikul C Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1424-31. PubMed ID: 15275728 [TBL] [Abstract][Full Text] [Related]
46. Fractionated intraluminal HDR 192Ir brachytherapy as palliative treatment in patients with endobronchial metastases from non-bronchogenic primaries. Stranzl H; Gabor S; Mayer R; Prettenhofer U; Wurzinger G; Hackl A Strahlenther Onkol; 2002 Aug; 178(8):442-5. PubMed ID: 12240550 [TBL] [Abstract][Full Text] [Related]
47. High dose rate afterloading intraluminal brachytherapy for advanced inoperable rectal carcinoma. Hoskin PJ; de Canha SM; Bownes P; Bryant L; Glynne Jones R Radiother Oncol; 2004 Nov; 73(2):195-8. PubMed ID: 15542167 [TBL] [Abstract][Full Text] [Related]
48. The role of brachytherapy in the treatment and control of central bronchial carcinoma. Macha HN; Freitag L Monaldi Arch Chest Dis; 1996 Aug; 51(4):325-8. PubMed ID: 8909019 [TBL] [Abstract][Full Text] [Related]
49. Clinical results of combined treatment conformal high-dose-rate iridium-192 brachytherapy and external beam radiotherapy using staging lymphadenectomy for localized prostate cancer. Hiratsuka J; Jo Y; Yoshida K; Nagase N; Fujisawa M; Imajo Y Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):684-90. PubMed ID: 15183471 [TBL] [Abstract][Full Text] [Related]
50. Postoperative vaginal cuff irradiation using high dose rate remote afterloading: a phase II clinical protocol. Noyes WR; Bastin K; Edwards SA; Buchler DA; Stitt JA; Thomadsen BR; Fowler JF; Kinsella TJ Int J Radiat Oncol Biol Phys; 1995 Jul; 32(5):1439-43. PubMed ID: 7635785 [TBL] [Abstract][Full Text] [Related]
51. A prospective analysis of high-dose-rate endobronchial brachytherapy in the palliation of obstructive symptoms in lung cancer patients: A single-institution experience. Goldberg M; Timotin E; Farrell T; Puksa S; Donde B; Sur R Brachytherapy; 2015; 14(5):655-61. PubMed ID: 25983031 [TBL] [Abstract][Full Text] [Related]
52. Sequential photodynamic therapy (PDT) and high dose brachytherapy for endobronchial tumour control in patients with limited bronchogenic carcinoma. Freitag L; Ernst A; Thomas M; Prenzel R; Wahlers B; Macha HN Thorax; 2004 Sep; 59(9):790-3. PubMed ID: 15333857 [TBL] [Abstract][Full Text] [Related]
54. [Combined endobronchial and percutaneous radiotherapy after implanting the nitinol alloy endotrachial stent for advanced lung carcinoma]. Yang G; Gao M; Chen Y Zhonghua Jie He He Hu Xi Za Zhi; 1999 May; 22(5):274-6. PubMed ID: 11775852 [TBL] [Abstract][Full Text] [Related]
55. High dose rate brachytherapy in patients with local recurrences after radiotherapy of non-small cell lung cancer. Sutedja G; Baris G; Schaake-Koning C; van Zandwijk N Int J Radiat Oncol Biol Phys; 1992; 24(3):551-3. PubMed ID: 1383178 [TBL] [Abstract][Full Text] [Related]
56. Second line palliative endobronchial radiotherapy with HDR Ir 192 in recurrent lung carcinoma. Zorlu AF; Selek U; Emri S; Gurkaynak M; Akyol FH Yonsei Med J; 2008 Aug; 49(4):620-4. PubMed ID: 18729305 [TBL] [Abstract][Full Text] [Related]
57. Does additional brachytherapy improve the effect of external irradiation? A prospective, randomized study in central lung tumors. Huber RM; Fischer R; Hautmann H; Pöllinger B; Häussinger K; Wendt T Int J Radiat Oncol Biol Phys; 1997 Jun; 38(3):533-40. PubMed ID: 9231677 [TBL] [Abstract][Full Text] [Related]
58. Effect and toxicity of endoluminal high-dose-rate (HDR) brachytherapy in centrally located tumors of the upper respiratory tract. Harms W; Schraube P; Becker H; Latz D; Herth F; Fritz P; Wannenmacher M Strahlenther Onkol; 2000 Feb; 176(2):60-6. PubMed ID: 10697652 [TBL] [Abstract][Full Text] [Related]
59. The use of high dose rate endobronchial brachytherapy to palliate symptomatic endobronchial recurrence of previously irradiated bronchogenic carcinoma. Bedwinek J; Petty A; Bruton C; Sofield J; Lee L Int J Radiat Oncol Biol Phys; 1992; 22(1):23-30. PubMed ID: 1727125 [TBL] [Abstract][Full Text] [Related]
60. Intermediate dose rate remote afterloading brachytherapy for intraluminal control of bronchogenic carcinoma. Speiser B; Spratling L Int J Radiat Oncol Biol Phys; 1990 Jun; 18(6):1443-8. PubMed ID: 1695215 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]